Wells Fargo lowered the firm’s price target on Bruker (BRKR) to $75 from $78 and keeps an Overweight rating on the shares. The silver lining in the second half of the year guide reset is that 2025 consensus numbers should rebase lower, which removes an overhang for investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: